Coloplast A/S

Coloplast A/S

Coloplast A/S

Date Founded



Holtedam 1-3,Humlebæk, Zealand 3050

Type of Company


Employees (Worldwide)



Medical Products & Equipment
Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Industrial Machinery & Manufacturing

Company Description

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use products, we create solutions that are sensitive to their special needs. They call this intimate healthcare. Their business includes ostomy care, urology and continence care, and wound and skin care. They operate globally, employing more than 9,000 people.

Contact Data
Trying to get in touch with decision makers at Coloplast A/S? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Executive Vice President & Chief Financial Officer

Vice President, Corporate Development & Strategy

Executive Vice President, Global Operations

Executive Vice President, Chronic Care

Senior Vice President, North America

Senior Vice President-Global Research & Development

Senior Vice President, Chronic Care, North America

Senior Vice President, Interventional Urology

Senior Vice President, Sales Europe

Board of Directors

Industrial Advisor at EQT Partners AB

Chief IR Officer at Danske Bank A/S

President & Chief Executive Officer at ALK-Abello A/S

Chief Executive Officer at MTG Broadcasting AB

Controller at Coloplast A/S

Industrial Advisor at Axcel Management A/S

Member, Board of Directors at Coloplast A/S

Member, Board of Directors at Coloplast A/S

Paths to Coloplast A/S
Potential Connections via
Relationship Science
Coloplast A/S
Owners & Shareholders
Details Hidden

Fundsmith is a fund management company established in 2010 by Terry Smith. The business is 100% owned and controlled by its partners, who have worked closely together over many years, and is headquartered in London with an office in Connecticut, USA. The investment process of the Fundsmith Equity Fund will be the only equity fund strategy that we employ and the Fundsmith Equity Fund is the main vehicle for Terry’s own investments.

Details Hidden

Comgest is an active, unconstrained, quality growth manager which aims to create portfolios offering regular, double-digit aggregated earnings per share growth per annum over a three to five-year investment horizon which typically leads to low portfolio turnover. To diversify a portfolio, the firm create value by focusing intense, bottom-up stock-picking approach on the companies they consider are able to sustain above-average growth in earnings per share. Comgest's choice of stocks is independent of benchmarks and do not follow any country or sector allocations. Their rigorous fundamental investment approach combines detailed financial and ESG analysis with frequent field research. The lead Portfolio Managers select companies from the list of investment candidates to create a concentrated portfolio, assigning weightings based on the relative attractiveness (risk/reward profile) of each company. A typical portfolio is concentrated to 25-50 stocks depending on the investment zone. Comgest buy stocks only when it is listed in the investment universe that may be added to portfolios, adding a company they already know well and/or have already owned in the past; and sell or trim positions when the valuation no longer appears attractive, there is a change in company fundamentals, and a superior risk-adjusted upside is identified and the holding is replaced.

Details Hidden

JAM's fund managers carry out rigorous research by examining company reports, news flow and through face-to-face meetings with the senior management of the companies in their investment universe. This process provides their teams with the intelligence required to asses whether a share or bond meets the criteria for inclusion in their portfolios. The outcome is a portfolio focused on those shares or bonds that satisfy their fund managers' individual investment process and in which they have the highest belief. JAM's fund managers employ a bottom-up approach to construct portfolios specializing in UK and European equities, global financials and emerging Europe. They complement their core strengths in equity and multi-manager products with multi-asset, fixed-income and absolute return offerings. While their fund managers work as a team to share stock ideas and debate market prospects, each manager has individual responsibility for their own portfolios. JAM regularly reviews key statistics for funds and utilizes tracking error, absolute volatility and factor risk at country, industry and stock level as their main measures of risk. Their SRI team aims to deliver long-term performance by investing in companies with positive growth, supported by trends in environmental and social policies and regulations focusing on clean energy, water management, green transport, waste management, sustainable living and environmental services.

Recent Transactions
Details Hidden

Coloplast A/S purchases Lilial SAS from Ouest Croissance Gestion SAS, Naxicap Partners SA

Details Hidden

Coloplast A/S purchases Comfort Medical LLC from Liberty Medical Holdings LLC

Details Hidden

Coloplast A/S purchases Mpathy Medical Devices Ltd.

Transaction Advisors
Investment Advisor

Advised onColoplast A/S purchases Mentor Corp. /Surgical Urology Business from Mentor Worldwide LLC

Legal Advisor

Advised onColoplast A/S purchases Unit of SSL International Plc from SSL International Plc


Advised onBaxter Deutschland GmbH purchases Coloplast Group /Nutrition Business from Coloplast A/S

Advisors & Consultants
Legal Advisor

Partner at Gibson, Dunn & Crutcher LLP

Legal Advisor

Partner at Faegre Baker Daniels LLP

Legal Advisor

Partner at O'Melveny & Myers LLP


Novolog (Pharm UP 1966) Ltd. is a health logistics, multinational pharmaceutical and medical device company. It supports local agents and manufacturers that markets and sells health-oriented products. The company distributes pharmaceutical and medical device products. It engages in refining the prescription drug and medical devices logistical supply chain management. The company services include logistics and added values. Novolog (Pharm UP 1966) was founded in 1966 and is headquartered in Modiin, Israel.

Key Stats and Financials As of 2019
Market Capitalization
Total Enterprise Value
Earnings Per Share
Net Profit
Total Debt
Total Equity
Enterprise Value Sales
Enterprise Value EBITDAOperating
TEVNet Income
Debt TEV
Details Hidden

Interface Biotech A/S develops products for the treatment of cartilage and bone disorders. The firm also offers cGMP culturing of human cells for implantation and research services. The company was founded in 1998 by Kurt Osther and is headquartered in Hoersholm, Denmark.

Details Hidden

Acarix AB engages in the provision of medical devices for monitoring Coronary Artery Disease. It develops and commercializes diagnostic tests based on its technology platform CADScor System. The company was founded by Peter Boman Samuelsen, Samuel Schmidt, Weimin Rong and Claus Bo Vöge Christensen in 2009 and is headquartered in Malmo, Sweden.

Details Hidden

Nordic Vaccine A/S engages in the development and commercialization of vaccines for prophylactic and therapeutic use. It offers Posintro that combines delivery and immunological properties for the development of prophylactic and therapeutic vaccines. The firm also provides needle free delivery systems, including TransVac, a novel patch system for pain-free, non-invasive, and transdermal delivery of vaccines. The company was founded in 2001 and is headquartered in Copenhagen, Denmark.

Nolato AB Industrial Conglomerates | Torekov, SN

Nolato AB engages in the development and manufacture of polymer product systems for customers in medical technology, telecommunications, hygiene, automotive products and other selected industrial sectors. It operates through the following segments: Medical Solutions, Integrated Solutions and Industrial Solutions. The Medical Solutions segment develops and manufactures complex product systems and components within medical technology, as well as advanced packaging solutions for pharmaceuticals and dietary supplements. The Integrated Solutions segment caters to two sectors, namely consumer electronics, and electromagnetic compatibility and thermal. The Industrial Solutions segment focuses on components and product systems for customers in the automotive industry, hygiene, packaging, gardening and forestry, domestic appliances, and other selected industrial segments. The company was founded in 1938 and is headquartered in Torekov, Sweden.

RTI Surgical, Inc. Hospitals & Patient Services | Alachua, FL

A leading provider of sterile biologic implants around the world, RTI Biologics, Inc. is at the forefront of tissue-based innovations that repair and support the natural healing of human bone and tissues. We continue to break new ground with developments that are changing regenerative medicine. RTI prepares human donated tissue and bovine tissue for transplantation through extensive testing and screening, precision shaping and proprietary, validated sterilization processes. These allograft and xenograft implants are used in spine, sports medicine, orthopedic, dental and other specialty surgeries. RTI’s innovations continuously raise the bar of science and safety for biologics—from being the first company to offer precision-tooled bone implants and assembled technology to maximize each gift of donation, to inventing validated sterilization processes that include viral inactivation steps. Two such processes—the BioCleanse® and Tutoplast® Tissue Sterilization Processes—sterilize tissue, are clinically successful and are scientifically proven to address donor-to-recipient disease transmission risk while preserving tissue strength and biocompatibility. These processes have a proven record of more than four million implants distributed with zero incidence of allograft-associated infection. Allograft is tissue that has been donated upon death by the donor. RTI honors the gift of tissue donation by treating the tissue with respect, by finding new ways to use the tissue to help patients and by helping as many patients as possible from each donation. The company is leading the evolution of biologics once again by offering a bovine based biological matrix, providing surgeons an expanded supply of safe, sterile tissue for their patients.

Veeva Systems, Inc. Other Business & Consulting Services | PLEASANTON, CA

Veeva Systems, Inc. engages in the provision of industry-specific, cloud-based software solutions for the life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage a regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007 and is headquartered in Pleasanton, CA.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

3M Company Industrial Machinery & Manufacturing - Saint Paul, Minnesota

3M Co. is a technology company, which manufactures industrial, safety and consumer products. It operates through the following five segments: Industrial, Safety & Graphics, Health Care, Electronics & Energy, and Consumer. The Industrial segment provides products, including tapes, abrasives, adhesives, ceramics, sealants, closure systems for personal hygiene products, acoustic systems products, specialty materials and filtration systems. The Safety & Graphics segment offers personal protection products, ransportation safety products, commercial graphics systems, commercial cleaning and protection products, floor matting, roofing granules, all protection products, self-contained breathing apparatus systems, and gas and flame detection instruments. The Health Care segment supplies medical and surgical equipment, skin health & infection prevention products, drug delivery systems, dental & orthodontic products, health information systems and food safety products. The Electronics & Energy segment involves in the optical films solutions for electronic displays, packaging and interconnection devices; insulating and splicing solutions; touch screens and touch monitors; renewable energy component solutions; and infrastructure protection products. The Consumer segment products includes sponges, scouring pads, high-performance cloths, consumer and office tapes, repositionable notes, indexing systems, home improvement products, home care products, protective material products, and consumer & office tapes, as well as adhesives. The company was founded by Henry S. Bryan, Hermon W. Cable, John Dwan, William A. McGonagle and J. Danley Budd in 1902 and is headquartered in St. Paul, MN.

Becton, Dickinson & Co. Medical Products & Equipment - Franklin Lakes, New Jersey

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in more than 50 countries worldwide.

Awards & Honors
Rank #23
Forbes - World's 100 Most Innovative Companies
Sponsored by Forbes Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Coloplast A/S. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Coloplast A/S's profile does not indicate a business or promotional relationship of any kind between RelSci and Coloplast A/S.